Dr Tuan Vo

Dr Tuan Vo

Postdoctoral Research Fellow

School of Biomedical Sciences and Pharmacy

Career Summary

Biography

Dr Tuan Vo is an Early Career Researcher, awarded his PhD in Medical and Molecular Genetics in 2024. His academic career and professional journey are focused on uncovering the complexities of cancer biology and translating these insights into impactful clinical applications.

During Dr Vo's doctoral studies at the University of Queensland, he focused on leveraging innovative spatial-omics technologies to explore tumor heterogeneity and the interplay between tumors and their microenvironments, with a particular emphasis on children’s brain cancers such as Diffuse Intrinsic Pontine Glioma (DIPG) and Medulloblastoma. Dr Vo's work also extended to other cancer types, including squamous cell carcinoma (SCC), and diseases like SARS-CoV-2 infection, where he applied spatial approaches to uncover molecular mechanisms driving disease progression and immune response. This multidisciplinary focus not only deepened Dr Vo's understanding of complex disease processes but also fueled his passion for developing advanced methodologies to tackle these challenges. Collaborating with diverse teams and addressing complex technical hurdles, such as optimizing the analysis of formalin-fixed paraffin-embedded samples, earned recognition from leading industry stakeholders, including 10X Genomics and BGI Australia.

As a Postdoctoral Research Fellow working as part of the Cancer Signalling Research Group (CSRG), led by Professor Matthew Dun, based at the University of Newcastle, Hunter Medical Research Institute, Dr Vo now applies his expertise to the study of Diffuse Midline Glioma (DMG), a devastating and fatal pediatric brain cancer where palliative radiotherapy is the only treatment available. By leveraging advanced spatial multi-omics technologies, Dr Vo investigates tumor-microenvironment interactions and their implications for therapeutic responses. This research is critically significant due to the urgent need for innovative treatments in this field. Dr Vo remains committed to translating these findings into clinical applications that address the unmet needs of patients with highly aggressive brain cancers, contributing to the development of personalized therapies that offer meaningful improvements in patient outcomes and their families.


Qualifications

  • DOCTOR OF PHILOSOPHY, University of Queensland
  • Master of Biotechnology Studies, Flinders University

Keywords

  • Children brain cancer
  • Diffuse intrinsic pontine glioma (DIPG)
  • Diffuse midline glioma (DMG)
  • Machine learning
  • Medulloblastoma
  • Single-cell omics
  • Spatial omics

Languages

  • English (Fluent)
  • Vietnamese (Mother)

Fields of Research

Code Description Percentage
310509 Genomics 20
340406 Molecular medicine 35
321199 Oncology and carcinogenesis not elsewhere classified 30
461199 Machine learning not elsewhere classified 15

Professional Experience

UON Appointment

Title Organisation / Department
Postdoctoral Research Fellow University of Newcastle
School of Biomedical Sciences and Pharmacy
Australia

Academic appointment

Dates Title Organisation / Department
17/5/2024 - 16/5/2025 Postdoctoral Research Fellow College of Health, Medicine and Wellbeing, University of Newcastle
Biomedical Sciences and Pharmacy
Australia
15/2/2023 - 15/2/2024 Senior Research Assistant Institute for Molecular Bioscience, The University of Queensland
Australia

Awards

Award

Year Award
2023 Poster Presentation Award, Children's Brain Cancer Conference 2023, Brisbane QLD
The Cure Starts Now Foundation
2021 Best Oral Presentation, Oz Single Cell 2021, Sydney NSW
Oz Single Cell
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Journal article (10 outputs)

Year Citation Altmetrics Link
2025 Vo T, Prakrithi P, Jones K, Yoon S, Lam PY, Kao YC, Ma N, Tan SX, Jin X, Zhou C, Crawford J, Walters S, Gupta I, Soyer PH, Khosrotehrani K, Stark MS, Nguyen Q, 'Assessing spatial sequencing and imaging approaches to capture the molecular and pathological heterogeneity of archived cancer tissues', Journal of Pathology, 265, 274-288 (2025) [C1]
DOI 10.1002/path.6383
2025 Kordowski A, Mulay O, Tan X, Vo T, Baumgartner U, Maybury MK, Hassall T, Harris L, Nguyen Q, Day BW, 'Spatial analysis of a complete DIPG-infiltrated brainstem reveals novel ligand-receptor mediators of tumour-to-TME crosstalk', Acta Neuropathologica Communications, 13 (2025)
DOI 10.1186/s40478-025-01952-x
2024 Dang TVT, Gillinder KR, Nguyen Q, Mulay O, Vo T, Mehdi AM, Zhou C, Brooks AJ, Leggatt GR, Hume DA, Frazer IH, Chandra J, 'Squamous cell carcinoma is associated with reduced IL34 expression, alterations in the Langerhans cell antigen-processing-presentation machinery and poor patient survival', Clinical and Translational Immunology, 13 (2024) [C1]
DOI 10.1002/cti2.70018
2023 Tan X, Causer A, Vo TQA, Ma N, Cheikh BB, Genovesi L, Gonzalez-Cruz J, Nguyen Q, Braubach O, 'Abstract 4703: Applying spatial omics and computational integrative analyses to study drug responses and cancer immune cell interactions', Cancer Research, 83, 4703-4703 (2023)
DOI 10.1158/1538-7445.am2023-4703
2023 Tan X, Grice LF, Tran M, Mulay O, Monkman J, Blick T, Vo T, Almeida AC, da Silva Motta J, de Moura KF, Machado-Souza C, Souza-Fonseca-Guimaraes P, Baena CP, de Noronha L, Guimaraes FSF, Luu HN, Drennon T, Williams S, Stern J, Uytingco C, Pan L, Nam A, Cooper C, Short K, Belz GT, Souza-Fonseca-Guimaraes F, Kulasinghe A, Nguyen Q, 'A robust platform for integrative spatial multi-omics analysis to map immune responses to SARS-CoV-2 infection in lung tissues', Immunology, 170, 401-418 (2023) [C1]
DOI 10.1111/imm.13679
2023 Vo T, Balderson B, Jones K, Ni G, Crawford J, Millar A, Tolson E, Singleton M, Kojic M, Robertson T, Walters S, Mulay O, Bhuva DD, Davis MJ, Wainwright BJ, Nguyen Q, Genovesi LA, 'Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition', Genome Medicine, 15 (2023) [C1]
DOI 10.1186/s13073-023-01185-4
2022 Xu T, Vo QAT, Barnett SJ, Ballard RA, Zhu Y, Franco CMM, 'Correction to: Revealing the underlying mechanisms mediated by endophytic actinobacteria to enhance the rhizobia—chickpea (Cicer arietinum L.) symbiosis (Plant and Soil, (2022), 474, 1-2, (299-318), 10.1007/s11104-022-05335-2)', Plant and Soil, 474, 319-320 (2022)
DOI 10.1007/s11104-022-05402-8
2022 Xu T, Vo QAT, Barnett SJ, Ballard RA, Zhu Y, Franco CMM, 'Revealing the underlying mechanisms mediated by endophytic actinobacteria to enhance the rhizobia - chickpea (Cicer arietinum L.) symbiosis', Plant and Soil, 474, 299-318 (2022) [C1]
DOI 10.1007/s11104-022-05335-2
2022 Vo T, Balderson B, Jones K, Crawford J, Millar A, Tolson E, Ruitenberg M, Robertson T, Bhuva D, Davis M, Wainwright B, Nguyen Q, Genovesi L, 'MEDB-06. Spatial transcriptomic analysis of Sonic Hedgehog Medulloblastoma identifies that loss of heterogeneity and induced differentiation underlies the response to CDK4/6 inhibition', Neuro-Oncology, 24, i105-i105 (2022)
DOI 10.1093/neuonc/noac079.381
2021 Vo QAT, Ballard RA, Barnett SJ, Franco CMM, 'Isolation and characterisation of endophytic actinobacteria and their effect on the growth and nodulation of chickpea (Cicer arietinum)', Plant and Soil, 466, 357-371 (2021)
DOI 10.1007/s11104-021-05008-6
Show 7 more journal articles

Preprint (3 outputs)

Year Citation Altmetrics Link
2025 Kim P, Kumar V, Garner N, Jayasingh O, Roman G, Walters S, Vo T, Nguyen Q, Bowles J, Woodruff T, Inder W, Hunt J, Heyde I, Oster H, Rawashdeh O, 'A systemic clock brake: Period1 stabilizes the circadian network under environmental stress' (2025)
DOI 10.1101/2025.06.12.659230
2024 Causer A, Lu T, Fitzgerald C, Newman A, Vu H, Tan X, Vo T, Cui C, Narayana VK, Whittle JR, Best SA, Freytag S, Nguyen Q, 'SpaMTP: Integrative Statistical Analysis and Visualisation of Spatial Metabolomics and Transcriptomics data' (2024)
DOI 10.1101/2024.10.31.621429
2024 Prakrithi P, Vo T, Vu H, Xiong Z, Nguyen L, Newman A, Whitehall V, Gonzalez Cruz JL, Gupta I, Nguyen Q, 'Unraveling lncRNA Diversity at a Single Cell Resolution and in a Spatial Context across Different Cancer Types' (2024)
DOI 10.1101/2024.08.12.607523
Edit

Grants and Funding

Summary

Number of grants 6
Total funding $4,919,281

Click on a grant title below to expand the full details for that specific grant.


20256 grants / $4,919,281

Sequential & Temporal Therapeutic Agility for the Treatment of Diffuse Midline Glioma$2,000,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Matt Dun, Doctor Ryan Duchatel, Doctor Tuan Vo, Doctor Evie Jackson, Dr Fatima Valdes Mora, Prof Dieter Heiland, Prof Nada Jabado, Doctor Sebastian Waszak, Dr Sabine Mueller, Associate Professor Mark Cowley, Dr Nicolas Vitanza, Mr Robert Salomon, Dr Laura de la Fuente, Dr Yolanda Sanguino, Miss Olive Loughnan, Santosh Valvi
Scheme MRFF - Paediatric Brain Cancer Research Grant
Role Investigator
Funding Start 2025
Funding Finish 2027
GNo G2400646
Type Of Funding C1300 - Aust Competitive - Medical Research Future Fund
Category 1300
UON Y

Unlocking Drug Penetration and Metabolomics: Pioneering Real-Time Drug Assessment$919,526

Funding body: ChadTough Defeat DIPG Foundation

Funding body ChadTough Defeat DIPG Foundation
Project Team Professor Matt Dun, Doctor Tuan Vo, A/Prof Arutha Kulasinghe, Dr Carl Koschmann, Doctor Sabine Mueller, AProf Arutha Kulasinghe
Scheme Game Changer Grant
Role Investigator
Funding Start 2025
Funding Finish 2027
GNo G2401412
Type Of Funding C3600 - International Philanthropy
Category 3600
UON Y

Sequential & Temporal Therapeutic Agility for the Treatment of Diffuse Midline Glioma$874,878

Funding body: RUN DIPG

Funding body RUN DIPG
Project Team Professor Matt Dun, Associate Professor Mark Cowley, Doctor Ryan Duchatel, Professor Henrik Heiland, Professor Nada Jabado, Doctor Evie Jackson, Doctor Sabine Mueller, Doctor Laura Rodriguez de la Fuente, Robert Salomon, Yolanda Sanguino, Dr Fatima Valdes Mora, Santosh Valvi, Dr Nicolas Vitanza, Doctor Tuan Vo, Doctor Sebastian Waszak
Scheme Research Grant
Role Investigator
Funding Start 2025
Funding Finish 2027
GNo G2500252
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

Sequential & Temporal Therapeutic Agility for the Treatment of Diffuse Midline Glioma$874,878

Funding body: Little Legs Foundation

Funding body Little Legs Foundation
Project Team Professor Matt Dun, Associate Professor Mark Cowley, Doctor Ryan Duchatel, Professor Henrik Heiland, Professor Nada Jabado, Doctor Evie Jackson, Doctor Sabine Mueller, Doctor Laura Rodriguez de la Fuente, Robert Salomon, Dr Fatima Valdes Mora, Dr Nicolas Vitanza, Doctor Tuan Vo, Doctor Sebastian Waszak
Scheme Research Grant
Role Investigator
Funding Start 2025
Funding Finish 2027
GNo G2500253
Type Of Funding C3200 – Aust Not-for Profit
Category 3200
UON Y

Sequential & Temporal Therapeutic Agility for the Treatment of Diffuse Midline Glioma$199,999

Funding body: Mark Hughes Foundation

Funding body Mark Hughes Foundation
Project Team Professor Matt Dun, Associate Professor Mark Cowley, Doctor Ryan Duchatel, Professor Henrik Heiland, Professor Nada Jabado, Doctor Evie Jackson, Doctor Sabine Mueller, Doctor Laura Rodriguez de la Fuente, Robert Salomon, Yolanda Sanguino, Dr Fatima Valdes Mora, Santosh Valvi, Dr Nicolas Vitanza, Doctor Tuan Vo, Doctor Sebastian Waszak
Scheme Research Funding
Role Investigator
Funding Start 2025
Funding Finish 2027
GNo G2500254
Type Of Funding Scheme excluded from IGS
Category EXCL
UON Y

Real time analysis of paediatric brain cancer therapies – optimisation of spatial multiomics for rapid assessment of drug effect$50,000

Funding body: Trustees of the Late RT Hall

Funding body Trustees of the Late RT Hall
Project Team Professor Matt Dun, Doctor Tuan Vo
Scheme Research Fund
Role Investigator
Funding Start 2025
Funding Finish 2025
GNo G2401687
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y
Edit

Research Supervision

Number of supervisions

Completed0
Current3

Current Supervision

Commenced Level of Study Research Title Program Supervisor Type
2025 PhD Optimising Treatment Strategies for Diffuse Midline Glioma utilising Multi-omic Characterisation of DMG Models PhD (Medical Biochemistry), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2024 PhD Integrated DMG Multi-omics Subtyping System PhD (Medical Genetics), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2023 PhD Targeting the extracellular matrix of paediatric brain tumours to promote response to systemic and immune-based therapies. PhD (Medical Biochemistry), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
Edit

Dr Tuan Vo

Position

Postdoctoral Research Fellow
Cancer Signalling Research Group
School of Biomedical Sciences and Pharmacy
College of Health, Medicine and Wellbeing

Contact Details

Email tuan.vo@newcastle.edu.au
Phone 0240550270
Link Twitter

Office

Room LS334
Building Life Science
Location Callaghan Campus
University Drive
Callaghan, NSW 2308
Australia
Edit